Biomarkers in Prediction of AMI
ConditionAcute Mesenteric Ischemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Tartu
About this trial
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older
Initial decision in favour of further diagnostics of mesenteric ischaemia
Disqualifiers
Age <18 years
Consent declined by patient or next of kin (delayed consent)
Chronic mesenteric ischaemia without an acute event
Immediate decision for withdrawal of further diagnostics and active treatment
Trial design
Design model
Single group
Treatments tested in this trial
Sequential blood samples
Diagnostic testSequential blood samples for diagnostic tests is the only intervention in thei study
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Patient with suspicion of acute mesenteric ischaemiaOther 1 intervention
Trial outcomes
Primary outcomes
1
Rate of correctly predicted cases of acute mesenteric ischaemia
Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers
Time frame
10 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov